Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$42.5B |
| 2 |
NVIDIA
NVDA
|
+$2.39B |
| 3 |
Walmart Inc
WMT
|
+$1.17B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 5 |
JPMorgan Chase
JPM
|
+$808M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Amazon
AMZN
|
+$843M |
| 3 |
Xcel Energy
XEL
|
+$674M |
| 4 |
Global Payments
GPN
|
+$623M |
| 5 |
Palantir
PLTR
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.11% |
| 2 | Financials | 7.1% |
| 3 | Communication Services | 5.53% |
| 4 | Consumer Discretionary | 5.34% |
| 5 | Healthcare | 4.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4126
Oramed Pharmaceuticals
ORMP
$175M
| $67.9K | ﹤0.01% |
19,966
+13,049
| +189% | +$44.3K |
|
4127
Utah Medical Products
UTMD
$227M
| $67.7K | ﹤0.01% |
1,092
-4,527
| -81% | -$285K |
|
4128
RBB Bancorp
RBB
$450M
| $67.6K | ﹤0.01% |
3,164
-21,993
| -87% | -$471K |
|
4129
NVE Corp
NVEC
$573M
| $67.6K | ﹤0.01% |
1,032
-6,513
| -86% | -$439K |
|
4130
Neumora Therapeutics
NMRA
$300M
| $67.3K | ﹤0.01% |
34,507
+3,583
| +12% | +$9.29K |
|
4131
Blue Ridge Bankshares
BRBS
$334M
| $67.2K | ﹤0.01% |
16,011
-89,451
| -85% | -$374K |
|
|
NXDR
4132
Nextdoor Holdings
NXDR
$1.04B
| $66.7K | ﹤0.01% |
47,618
-296,278
| -86% | -$515K |
|
4133
American Battery Technology Co
ABAT
$361M
| $66.7K | ﹤0.01% |
23,889
-165,268
| -87% | -$638K |
|
4134
CALL
Molina Healthcare
MOH
$10.4B
| $66.7K | ﹤0.01% |
500
-20,100
| -98% | -$3.2M |
|
4135
Zai Lab
ZLAB
$2.65B
| $66.4K | ﹤0.01% |
3,531
+3,530
| +353,000% | +$65.4K |
|
|
SUPX
4136
SuperX AI Technology Ltd
SUPX
$295M
| $66.4K | ﹤0.01% |
8,300
+5,666
| +215% | +$72.1K |
|
4137
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
$4.06B
| $66.3K | ﹤0.01% |
2,850
| – | – |
|
4138
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.86B
| $66.2K | ﹤0.01% |
2,733
| – | – |
|
4139
iShares MSCI EAFE Value ETF
EFV
$30B
| $66.2K | ﹤0.01% |
+890
| New | +$66.9K |
|
4140
Quad
QUAD
$507M
| $66K | ﹤0.01% |
9,982
-34,989
| -78% | -$226K |
|
|
TE
4141
CALL
T1 Energy
TE
$1.48B
| $65.8K | ﹤0.01% |
+15,000
| New | +$110K |
|
4142
PLAYSTUDIOS Inc
MYPS
$86.3M
| $65.7K | ﹤0.01% |
140,078
-118,378
| -46% | -$64.1K |
|
4143
KULR Technology Group
KULR
$127M
| $65.7K | ﹤0.01% |
27,724
-33,895
| -55% | -$105K |
|
4144
Titan Machinery
TITN
$426M
| $65.6K | ﹤0.01% |
3,926
-28,988
| -88% | -$503K |
|
4145
OP Bancorp
OPBK
$233M
| $65.4K | ﹤0.01% |
4,916
-13,460
| -73% | -$185K |
|
4146
SKYX Platforms
SKYX
$164M
| $65.3K | ﹤0.01% |
58,313
-53,596
| -48% | -$112K |
|
4147
Defiance Quantum ETF
QTUM
$5.58B
| $65.2K | ﹤0.01% |
608
-176
| -22% | -$20.1K |
|
|
EUAD
4148
Select STOXX Europe Aerospace & Defense ETF
EUAD
$1.25B
| $65.2K | ﹤0.01% |
+1,600
| New | +$72.2K |
|
4149
W&T Offshore
WTI
$577M
| $65K | ﹤0.01% |
19,059
-135,497
| -88% | -$335K |
|
4150
Sera Prognostics
SERA
$78.7M
| $64.9K | ﹤0.01% |
31,967
-4,755
| -13% | -$12.2K |
|
Similar funds
Barclays's Q1 2026 Portfolio in Review
As of Q1 2026, Barclays held 5,572 positions worth $416B, down 0.11% from $417B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $19.3B of net new capital in Q1 2026, opening 398 new positions and adding to 1,219 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Tesla, an estimated $1.26B trimmed.
- Barclays's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q1 2026, an estimated $42.5B increase.
- Barclays's biggest Q1 2026 reduction was Tesla, cutting an estimated $1.26B.
- Barclays fully exited CyberArk in Q1 2026, selling an estimated $232M.
- Barclays's ten largest holdings make up 37% of its $416B portfolio in Q1 2026.
- Barclays opened 398 new positions and closed 564 in Q1 2026.
- Barclays's portfolio value fell 0.11% quarter-over-quarter to $416B.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.